vs

Side-by-side financial comparison of Ardent Health, Inc. (ARDT) and Ingersoll Rand (IR). Click either name above to swap in a different company.

Ingersoll Rand is the larger business by last-quarter revenue ($2.1B vs $1.6B, roughly 1.3× Ardent Health, Inc.). Ingersoll Rand runs the higher net margin — 12.7% vs 2.8%, a 9.9% gap on every dollar of revenue.

Goodlife Health Clubs is a chain of health clubs, with more than 80 locations in Australia.

Ingersoll Rand Inc. is an American multinational company that provides flow creation and industrial products. The company was formed in February 2020 through the spinoff of the industrial segment of Ingersoll-Rand plc and its merger with Gardner Denver. Its products are sold under more than 40 brands across all major global markets.

ARDT vs IR — Head-to-Head

Bigger by revenue
IR
IR
1.3× larger
IR
$2.1B
$1.6B
ARDT
Higher net margin
IR
IR
9.9% more per $
IR
12.7%
2.8%
ARDT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ARDT
ARDT
IR
IR
Revenue
$1.6B
$2.1B
Net Profit
$45.0M
$266.1M
Gross Margin
42.6%
Operating Margin
5.8%
18.7%
Net Margin
2.8%
12.7%
Revenue YoY
10.1%
Net Profit YoY
15.8%
EPS (diluted)
$0.32
$0.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARDT
ARDT
IR
IR
Q4 25
$1.6B
$2.1B
Q3 25
$1.6B
$2.0B
Q2 25
$1.6B
$1.9B
Q1 25
$1.5B
$1.7B
Q4 24
$1.9B
Q3 24
$1.4B
$1.9B
Q2 24
$1.5B
$1.8B
Q1 24
$1.7B
Net Profit
ARDT
ARDT
IR
IR
Q4 25
$45.0M
$266.1M
Q3 25
$-23.5M
$244.1M
Q2 25
$73.0M
$-115.3M
Q1 25
$41.4M
$186.5M
Q4 24
$229.8M
Q3 24
$26.3M
$221.6M
Q2 24
$42.8M
$185.0M
Q1 24
$202.2M
Gross Margin
ARDT
ARDT
IR
IR
Q4 25
42.6%
Q3 25
43.7%
Q2 25
43.7%
Q1 25
44.6%
Q4 24
42.9%
Q3 24
43.8%
Q2 24
43.9%
Q1 24
44.7%
Operating Margin
ARDT
ARDT
IR
IR
Q4 25
5.8%
18.7%
Q3 25
-0.1%
19.2%
Q2 25
7.4%
4.0%
Q1 25
5.0%
17.6%
Q4 24
20.0%
Q3 24
3.9%
19.1%
Q2 24
5.6%
15.1%
Q1 24
17.6%
Net Margin
ARDT
ARDT
IR
IR
Q4 25
2.8%
12.7%
Q3 25
-1.5%
12.5%
Q2 25
4.4%
-6.1%
Q1 25
2.8%
10.9%
Q4 24
12.1%
Q3 24
1.8%
11.9%
Q2 24
2.9%
10.2%
Q1 24
12.1%
EPS (diluted)
ARDT
ARDT
IR
IR
Q4 25
$0.32
$0.67
Q3 25
$-0.17
$0.61
Q2 25
$0.52
$-0.29
Q1 25
$0.29
$0.46
Q4 24
$0.57
Q3 24
$0.19
$0.54
Q2 24
$0.34
$0.45
Q1 24
$0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARDT
ARDT
IR
IR
Cash + ST InvestmentsLiquidity on hand
$709.6M
$1.2B
Total DebtLower is stronger
$1.1B
$4.8B
Stockholders' EquityBook value
$1.3B
$10.1B
Total Assets
$5.3B
$18.3B
Debt / EquityLower = less leverage
0.84×
0.47×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARDT
ARDT
IR
IR
Q4 25
$709.6M
$1.2B
Q3 25
$609.4M
$1.2B
Q2 25
$540.6M
$1.3B
Q1 25
$495.0M
$1.6B
Q4 24
$1.5B
Q3 24
$563.1M
$1.4B
Q2 24
$334.5M
$1.1B
Q1 24
$1.5B
Total Debt
ARDT
ARDT
IR
IR
Q4 25
$1.1B
$4.8B
Q3 25
$1.1B
$4.8B
Q2 25
$1.1B
$4.8B
Q1 25
$1.1B
$4.8B
Q4 24
$4.8B
Q3 24
$1.1B
$4.8B
Q2 24
$1.1B
$4.8B
Q1 24
$2.7B
Stockholders' Equity
ARDT
ARDT
IR
IR
Q4 25
$1.3B
$10.1B
Q3 25
$1.2B
$10.1B
Q2 25
$1.3B
$10.1B
Q1 25
$1.2B
$10.5B
Q4 24
$10.2B
Q3 24
$1.0B
$10.3B
Q2 24
$739.9M
$10.0B
Q1 24
$9.9B
Total Assets
ARDT
ARDT
IR
IR
Q4 25
$5.3B
$18.3B
Q3 25
$5.2B
$18.2B
Q2 25
$5.0B
$18.1B
Q1 25
$4.9B
$18.4B
Q4 24
$18.0B
Q3 24
$4.8B
$18.2B
Q2 24
$4.6B
$17.8B
Q1 24
$15.5B
Debt / Equity
ARDT
ARDT
IR
IR
Q4 25
0.84×
0.47×
Q3 25
0.88×
0.47×
Q2 25
0.87×
0.47×
Q1 25
0.93×
0.45×
Q4 24
0.47×
Q3 24
1.08×
0.47×
Q2 24
1.46×
0.48×
Q1 24
0.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARDT
ARDT
IR
IR
Operating Cash FlowLast quarter
$223.4M
$499.0M
Free Cash FlowOCF − Capex
$461.5M
FCF MarginFCF / Revenue
22.1%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
4.97×
1.88×
TTM Free Cash FlowTrailing 4 quarters
$1.2B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARDT
ARDT
IR
IR
Q4 25
$223.4M
$499.0M
Q3 25
$154.4M
$354.6M
Q2 25
$117.5M
$245.7M
Q1 25
$-24.8M
$256.4M
Q4 24
$526.2M
Q3 24
$89.7M
$404.0M
Q2 24
$304.9M
Q1 24
$161.6M
Free Cash Flow
ARDT
ARDT
IR
IR
Q4 25
$461.5M
Q3 25
$325.5M
Q2 25
$210.4M
Q1 25
$222.7M
Q4 24
$490.9M
Q3 24
$374.3M
Q2 24
$283.1M
Q1 24
$99.3M
FCF Margin
ARDT
ARDT
IR
IR
Q4 25
22.1%
Q3 25
16.6%
Q2 25
11.1%
Q1 25
13.0%
Q4 24
25.9%
Q3 24
20.1%
Q2 24
15.7%
Q1 24
5.9%
Capex Intensity
ARDT
ARDT
IR
IR
Q4 25
1.8%
Q3 25
1.5%
Q2 25
1.9%
Q1 25
2.0%
Q4 24
1.9%
Q3 24
1.6%
Q2 24
1.2%
Q1 24
3.7%
Cash Conversion
ARDT
ARDT
IR
IR
Q4 25
4.97×
1.88×
Q3 25
1.45×
Q2 25
1.61×
Q1 25
-0.60×
1.37×
Q4 24
2.29×
Q3 24
3.41×
1.82×
Q2 24
1.65×
Q1 24
0.80×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARDT
ARDT

Segment breakdown not available.

IR
IR

Transferred At Point In Time$1.5B71%
Transferred Over Time$193.0M9%
Precision And Science Technologies Segment$183.1M9%
Acquisitions In2024$175.6M8%
Acquisitions In2025$70.8M3%

Related Comparisons